| |
| |
|
| Insider
Information: |
Silverman Joshua |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
578,364 |
|
|
Indirect Shares
|
2,132,322 |
|
|
| Direct
Value |
$433,383 |
|
|
|
Indirect Value
|
$1,975,831 |
|
|
| Total
Shares |
2,710,686 |
|
|
| Total
Value |
$2,409,213 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -13.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
National Holdings Corp |
NHLD |
Director |
|
0 |
2016-09-12 |
414,323 |
Premium* |
|
|
MGT Capital Investments |
MGT |
10% Owner |
|
0 |
2014-09-29 |
1,039,096 |
Premium* |
|
|
Alanco Technologies Inc |
ALAN |
Director |
|
0 |
2016-02-25 |
474,398 |
Premium* |
|
|
Protagenic Therapeutics Ord Shs |
PTIX |
Director |
2016-06-17 |
45,000 |
2016-06-17 |
0 |
Premium* |
|
|
Ayro Inc |
AYRO |
Director |
2023-08-01 |
395,493 |
2021-06-04 |
1,172 |
Premium* |
|
|
Marker Therapeutics Inc |
MRKR |
Director |
2018-10-16 |
17,221 |
2018-10-16 |
153,333 |
Premium* |
|
|
MyMD Pharmaceuticals, Inc |
MYMD |
Director |
2021-04-16 |
71,175 |
2020-01-01 |
0 |
Premium* |
|
|
Petros Pharmaceuticals, Inc. |
PTPI |
Director |
2023-04-26 |
11,237 |
2020-12-01 |
0 |
Premium* |
|
|
Synaptogenix, Inc. |
SNPX |
Director |
2022-12-16 |
38,238 |
|
0 |
Premium* |
|
|
PharmaCyte Biotech Inc |
PMCB |
Director |
|
0 |
2022-08-15 |
50,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NHLD |
National Holdings Corp |
Director |
– • – |
2014-07-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,286,455 |
|
- |
|
| MGT |
MGT Capital Investments |
10% Owner |
– – • |
2014-09-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,039,096 |
|
- |
|
| ALAN |
Alanco Technologies Inc |
Director |
– • – |
2016-02-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
474,398 |
|
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2016-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
268,605 |
|
- |
|
| SNPX |
Synaptogenix, Inc. |
Director |
– • – |
2021-06-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| PMCB |
PharmaCyte Biotech Inc |
Director |
– • – |
2022-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
50,000 |
|
- |
|
| MRKR |
Marker Therapeutics Inc |
Director |
– • – |
2017-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
13,115 |
13,115 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
I/I |
5,109 |
5,109 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
Director |
– • – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
I/I |
153,333 |
153,333 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
Director |
– • – |
2018-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,106 |
17,221 |
0 |
- |
|
| AYRO |
Ayro Inc |
|
• • – |
2019-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
75,950 |
84,887 |
0 |
- |
|
| MYMD |
MyMD Pharmaceuticals, Inc |
Director |
– • – |
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,201 |
5,201 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,756 |
9,756 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2020-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
122,547 |
132,303 |
0 |
- |
|
| PTPI |
Petros Pharmaceuticals, I... |
Director |
– • – |
2020-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
42,000 |
174,303 |
0 |
- |
|
| MYMD |
MyMD Pharmaceuticals, Inc |
Director |
– • – |
2021-04-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
109,500 |
112,101 |
0 |
- |
|
| SNPX |
Synaptogenix, Inc. |
Director |
– • – |
2021-07-13 |
4/A |
A |
$0.00 |
$0 |
D/D |
42,250 |
57,250 |
0 |
- |
|
| SNPX |
Synaptogenix, Inc. |
Director |
– • – |
2021-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
105,000 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
114,729 |
250,024 |
0 |
- |
|
| PTPI |
Petros Pharmaceuticals, I... |
Director |
– • – |
2023-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,515 |
4,515 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
197,333 |
420,160 |
0 |
- |
|
| PTPI |
Petros Pharmaceuticals, I... |
Director |
– • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,722 |
11,237 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2022-11-01 |
4 |
S |
$0.59 |
$4,245 |
D/D |
(7,171) |
229,998 |
0 |
- |
|
| AYRO |
Ayro Inc |
Director |
– • – |
2023-01-30 |
4 |
AS |
$0.71 |
$5,108 |
D/D |
(7,171) |
222,827 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
